Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised, Double-Blind Study of Ticagrelor vs Aspirin in Acute Ischaemic Stroke or TIA
jRCT2080222431Phase 3
- Sponsor
- AstraZeneca
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ticagrelor in brain infarction and transient ischaemic attack (TIA) (2 arms), sponsored by AstraZeneca.
02
Drugs
ticagrelor
03
Conditions
brain infarctiontransient ischaemic attack (TIA)
Beyond the preview
Go deeper on jRCT2080222431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222431.